Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A subtype of classical Hodgkin lymphoma with scattered Hodgkin and Reed-Sternberg cells and a nodular or less often diffuse cellular background consisting of small lymphocytes and with an absence of neutrophils and eosinophils. (WHO, 2008)
3 clinical trials registered. Interventions under study include drug therapy, biologic therapy, other interventions, and procedural interventions. Pipeline includes 2 PHASE3, 1 PHASE2. Research is primarily sponsored by academic and government institutions.
3 publications have been identified in PubMed for Hodgkin's lymphoma, lymphocytic-histiocytic predominance. Research spans Case Report / Case Series (67%) and Review / Meta-Analysis (33%).
Wymer GEY (2025). [PMID: 40740618](https://pubmed.ncbi.nlm.nih.gov/40740618/). *Case Rep Hematol*. [Case Report / Case Series]
Le Gatt P (2024). [PMID: 39677084](https://pubmed.ncbi.nlm.nih.gov/39677084/). *Cureus*. [Case Report / Case Series]
Ferry JA (2024). [PMID: 38978094](https://pubmed.ncbi.nlm.nih.gov/38978094/). *J Hematol Oncol*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 7:31 PM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning Hodgkin's lymphoma, lymphocytic-histiocytic predominance
Updated Apr 1, 2026
Recent research highlights a significant breakthrough in understanding the intersection of cardio-obstetric care and Hodgkin's lymphoma. This study may pave the way for improved management strategies in pregnant patients diagnosed with this rare cancer.
A recent study highlights vanishing bile duct syndrome as a rare hepatic paraneoplastic syndrome associated with Hodgkin's lymphoma. This discovery may enhance understanding of the disease's complications and guide future research.